Immune Modulation

Study Results in Melbourne Indicates TBL-12 Beneficial to Patient Well-Being

Published in AIDS Weekly, February 16th, 1998

Marine Research USA Inc. (Marine), Salt Lake City, Utah, has received initial positive results from a study of HIV/AIDS patients in Melbourne, Australia, which is sponsored by the Victorian AIDS Council in cooperation with Marine Research Pty. Ltd., (Marine Pty. Ltd.) the wholly owned Australian affiliate of Marine Research USA.

Dr. Claudio Villella (MBBS), Centre Clinic in St. Kilda, provided Marine with an initial written summary from the study after 20 weeks of the program completed in October 1997. The study continues and an additional progress report is expected at the end of February 1998.

According to Villella's letter to the company,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry